How and Why is hacked by viruses?

Identification: Jha, Sudhakar


How and Why is hacked by viruses?
Vanitha Krishna Subbaiah1, Yanzhou Zhang1, Deepa Rajagopalan1, 2, Lissa Nurrul Abdullah1, Nicole Shu Ling Yeo-Teh1,4, Tomaić Vjekoslav5, Lawrence Banks5, Michael P. Myers5, Edward Kai-Hua Chow1,3, Sudhakar Jha1, 2
1Cancer Science Institute of Singapore, 2Department of Biochemistry, 3Department of Pharmacology, Yong Loo Lin School of Medicine and 4NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore, 5International Centre for Genetic Engineering and Biotechnology, Trieste, Italy
TIP60 is an essential lysine acetyl transferase, involved in transcriptional regulation, checkpoint activation and p53-directed pro-apoptotic pathways. The cellular levels, stability and activity of TIP60 are tightly regulated. In the case of cervical cancers, we have earlier shown that human papillomavirus (HPV) E6 oncogene of both high- and low-risk categories destabilize TIP60. This in turn relieves cellular promoters from TIP60-initiated repression and abrogates p53-dependent activation of apoptotic pathway. Degradation of TIP60, therefore, allows high- and low-risk HPV to promote cell proliferation and cell survival. In this conference, I will discuss our efforts to identify the mechanism of TIP60 destabilization by E6, and its implications in cervical cancer progression. Briefly, we have discovered EDD1 (also known as UBR5), an E3 ligase generally overexpressed in cancers as a novel interacting partner of TIP60 and show that EDD1 negatively regulates TIP60's stability through the proteasome pathway. Interestingly, HPV E6 utilizes this function of EDD1 to destabilize TIP60. By using in vitro cell culture models and in vivo mouse models we show that gain of function of TIP60, or depletion of EDD1 in HPV positive cervical cancer cells significantly inhibits cell growth. In summary, we have discovered a novel ligase through which E6 destabilizes TIP60. Currently, in the absence of an effective therapeutic vaccine, cervical cancer still remains to be a major disease burden. Hence, our studies implying a distinct tumor suppressor role for TIP60 in cervical cancers shows that reactivation of TIP60 could be of therapeutic value.


Credits: None available.

You must be logged in and own this product in order to post comments.